[1]原 婧,唐闻达,徐 喆,等.亚单位疫苗微粒传递系统的制备材料与方法研究进展[J].中国预防兽医学报,2017,(10):861-864.[doi:10.3969/j.issn.1008-0425.201605019]
 [J].Chinese journal of preventive veterinary medicine,2017,(10):861-864.[doi:10.3969/j.issn.1008-0425.201605019]
点击复制

亚单位疫苗微粒传递系统的制备材料与方法研究进展()
分享到:

《中国预防兽医学报》[ISSN:1008-0589/CN:23-1417/S]

卷:
期数:
2017年10
页码:
861-864
栏目:
出版日期:
2017-11-15

文章信息/Info

文章编号:
1008-0589(2017)10-0861-04
作者:
 

原 婧唐闻达徐 喆尹荣焕*

 (沈阳农业大学 畜牧兽医学院/辽宁省人兽共患病研究重点实验室,辽宁 沈阳 110866)
分类号:
S851.35
DOI:
10.3969/j.issn.1008-0425.201605019
文献标志码:
B

参考文献/References:

[1]Azad A A, Mckern N M, Macreadie I G, et al.Physicochemical and immunological characterization of recombinant host-protective antigen (VP2) of infectious bursal disease virus [J]. Vaccine, 1991, 9(10): 715-722.
[2]赵玉康,田振中. 鸡传染性法氏囊病灭活苗与基因工程亚单位疫苗免疫效果比较[J]. 新疆畜牧业,2013,11:34-35.
[3]Brewer J M.(How) do aluminium adjuvants work? [J]. Immunol Lett, 2006, 102(1): 10-15.
[4]李娜,周伟芳,刘慧敏,等. 疫苗佐剂的研究现状和发展趋势[J]. 中国预防兽医学报,2013,35(1):81-86.
[5]刘玉莹,陈小明,王连艳,等. 鱼精蛋白对PLA微球佐剂的调控[J]. 过程工程学报,2013,13(4):646-653.
[6]崔福德,石凯,寸冬梅. 蛋白多肽类药物纳米粒口服给药系统的研究进展[J]. 沈阳药科大学学报,2010,12:946-951.
[7]韩斐,胡懿郃,汪龙. 聚乳酸-羟基乙酸载药微球制备工艺研究进展[J]. 中国医学物理学杂志,2016,(01):92-97.
[8]Akagi T, Baba M, Akashi M. Biodegradable nanoparticles as vaccine adjuvants and delivery systems: regulation of immune responses by nanoparticle-based vaccine [M]. Berlin, Heidelberg: Springer Berlin Heidelberg, 2012.
[9]金媛媛,赵凯,孙庆申,等. 微球制剂在疫苗中的应用及研究进展[J].中国预防兽医学报,2008,30(01):76-80.
[10]Zhou Ping, An Tong, Zhao Chuan, et al. Lactosylated PLGA nanoparticles containing ε-polylysine for the sustained release and liver-targeted delivery of the negatively charged proteins [J].Int J Pharm, 2015, 478(2): 633-643.
[11]肖小军,张慧云,刘晓宇,等. 以PLGA为佐剂的花粉过敏原疫苗特异性免疫治疗过敏性鼻炎的研究[J]. 南昌大学学报(医学版),2015,6:1-5.
[12]Iyer V, Cayatte C, Marshall J D, et al. Feasibility of freeze-drying oil-in-water emulsion adjuvants and subunit proteins to enable single-vial vaccine drug products [J]. J Pharm Sci, 2017, 106(6): 1490-1498.
[13]Derman S, Mustafaeva Z A, Abamor E S, et al. Preparation, characterization and immunological evaluation: canine parvovirus synthetic peptide loaded PLGA nanoparticles [J]. J Biomed Sci, 2015, 22(1):89.
[14]任建敏,邹全明,王缚鲲,et al. 聚乳酸类定向缓释疫苗微粒投递系统的应用进展[J]. 国外医学(生物医学工程分册),2000,03:182-186.
[15]Qiu Shao-hui, Wei Qiang, Liang Zheng-lun, et al. Biodegradable polylactide microspheres enhance specific immune response induced by Hepatitis B surface antigen [J]. Hum Vaccines Immunother, 2014, 10(8):2350-2356.
[16]贾成成,王连艳,方颖,等. PLGA微球粒径对HPV L1五聚体候选疫苗免疫效果的调控[J]. 过程工程学报,2013, 13(4):638-644.
[17]白洁,何应. 喷雾干燥技术在蛋白、多肽类药物微球制备中的应用[J]. 药学进展,2007,31(7):298-302.
[18]Fei Yu, Yang Li, Chang Sheng-liu, et al. Enteric-coated capsules filled with mono-disperse micro-particles containing PLGA-lipid-PEG nanoparticles for oral delivery of insulin [J]. Int J Pharm, 2015, 484(1-2): 181-191.
[19]Yu Zhong-shui, Johnston K P, Williams R O. 3rd. Spray freezing into liquid versus spray-freeze drying: influence of atomization on protein aggregation and biological activity[J]. Eur J Pharm Sci, 2006, 27(1): 9-18.
[20]Zhang Jian-xiang, Zhu Kang-jie, Chen Dian. Preparation of bovine serum albumin loaded poly (D, L-lactic-co-glycolic acid) microspheres by a modified phase separation technique [J]. J Microencapsul, 2005, 22(2): 117-126.
[21]Kim H K, Chung H J, Park T G, et al. Biodegradable polymeric microspheres with "open/closed" pores for sustained release of human growth hormone [J]. J Control Release, 2006, 112(2): 167-174.
[22]Baxendale A, Hooff P V, Durrant L G, et al. Single shot tetanus vaccine manufactured by a supercritical fluid encapsulation technology [J]. Int J Pharm, 2011, 413(1-2): 147-154.
[23]Malathi B, Mona S, Thiyagarajan D, et al. Immunopotentiating nano-chitosan as potent vaccine carter for efficacious prophylaxis of filarial antigens [J]. Int J Biol Macromol, 2015, 73: 131-137.
[24]Sonaje K, Lin Yu-hsin, Juang J H, et al. In vivo evaluation of safety and efficacy of self-assembled nanoparticles for oral insulin delivery [J]. Biomater, 2009, 30(12): 2329-2339.
[25]俞怡晨,姚炎庆,张亚琼,等. 壳聚糖-海藻酸盐纳米粒子的制备及其对BSA的载药与释放特性[J]. 功能高分子学报,2005,04:598-601.
[26]Fu Hong-xing, Li Hui, Wu Lan-lan, et al. Preparation and microscopy examination of alginate-poly-L-lysine-alginate microcapsules [J]. Drug Dev Ind Pharm, 2014, 40(11): 1523-1529.
[27]Nan Fang-fang, Wu Jie, Qi Feng, et al. Uniform chitosan-coated alginate particles as emulsifiers for preparation of stable Pickering emulsions with stimulus dependence [J]. Colloids Surf, A, 2014, 456(8m): 246-252.
[28]Attasart P, Boonma S, Sunintaboon P, et al. Inhibition of Plasmodium falciparum proliferation in vitro by double-stranded RNA nanoparticle against malaria topoisomerase II [J]. Exp Parasitol, 2016, 164: 84-90.
[29]Zhang Jing, Chen Xi-guang, Huang Lu, et al. Self-assembled polymeric nanoparticles based on oleic acid-grafted chitosan oligosaccharide: biocompatibility, protein adsorption and cellular uptake[J]. J Mater Sci Mater Med, 2012, 23(7): 1775-1783.
[30]Shima F, Akagi T, Akashi M. Effect of hydrophobic side chains in the induction of immune responses by nanoparticle adjuvants consisting of amphiphilic poly (γ-glutamic acid) [J]. Biomol Eng, 2015, 54(4): 431-443.
(本文编辑:彭永刚)

更新日期/Last Update: 2017-11-07